Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

ProbioGen AG. (4/1/10). "Press Release: ProBioGen Is Granted Divisional Patent on Its Proprietary AGE1 Cell Line". Berlin.

Organisations Organisation ProBioGen AG
  Group Minapharm (Group)
  Organisation 2 IDT Biologika GmbH
  Group Klocke (Group)
Products Product AGE1.CR duck cell line
  Product 2 vaccine technology
Persons Person Sandig, Volker (ProBioGen 201004 promoted CSO since 2000 at ProBiogGen before Merck US)
  Person 2 Unterrainer, Gertraud (ProBioGen 200710– CFO before Biovertis)

ProBioGen AG, a leading biotechnology company in cell engineering and production of biopharmaceuticals, today announced that it has been granted a divisional patent on its AGE1 cell line.

The patent covers the production of Modified Vaccinia Ankara (MVA) in duck cell lines. As these cells are free from endogenous particle-associated retrovirus activity, they are superior to current production substrates derived from chicken. The discovery has wide implications for the industrial production of one of the most promising recombinant vaccine vectors against infectious disease challenges such as HIV and malaria.

“The granted divisional patent further strengthens ProBioGen's proprietary platform that extends from innovative host cell lines to chemically defined production processes for highly attenuated viruses,” said Dr. Volker Sandig, Chief Scientific Officer of ProBioGen. An additional application on AGE1 with yet broader implications has been filed.

Record changed: 2017-04-02


Picture [LSUS] – The Business Web Portal 650x112px

More documents for Minapharm (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top